id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-272937-ala32ub5	Zhao, Xuan	Mesenchymal stem cells represent a potential therapeutic option for coronavirus disease 2019-related acute respiratory distress syndrome	2020-06-10		.txt	text/plain	1269	79	44	title: Mesenchymal stem cells represent a potential therapeutic option for coronavirus disease 2019-related acute respiratory distress syndrome [1] reported that the transplantation of allogeneic menstrual-blood-derived mesenchymal stem cells (MSCs) significantly reduced the mortality of influenza A (H7N9)-virus-induced acute respiratory distress syndrome (ARDS) without harmful side effects. Multiple studies have shown that fulminant pneumonia and ARDS can be induced by various viral infections, such as severe acute respiratory syndrome coronavirus (SARS-CoV) [4] , Middle East respiratory syndrome coronavirus (MERS-CoV) [5] , and H7N9 virus [6] . This is the first meaningful report demonstrating both the short-and long-term effectiveness of MSC transplantation to treat ARDS caused by virus infection. Clinical study of mesenchymal stem cell treating acute respiratory distress syndrome induced by epidemic influenza A (H7N9) infection: a hint for COVID-19 treatment. The effect of acute respiratory distress syndrome on bone marrow-derived mesenchymal stem cells	./cache/cord-272937-ala32ub5.txt	./txt/cord-272937-ala32ub5.txt